Pharma-Bio Serv (PBSV) Free Cash Flow Growth (1y) (2011 - 2026)
Pharma-Bio Serv (PBSV) Free Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn | 29.17% |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn | 30.81% |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn | 26.21% |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn | 774.21% |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn | 10.61% |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn | -19.89% |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn | 18.30% |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn | -105.58% |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn | 68.61% |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | 8.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 8.60% |
| Oct 31, 2025 | 455.41% |
| Jul 31, 2025 | 134.88% |
| Apr 30, 2025 | 56.35% |
| Jan 31, 2025 | -159.23% |
| Oct 31, 2024 | -125.35% |
| Jul 31, 2024 | -170.26% |
| Apr 30, 2024 | -179.32% |
| Jan 31, 2024 | -16.44% |
| Oct 31, 2023 | 25.03% |
| Jul 31, 2023 | -13.32% |
| Apr 30, 2023 | 44.33% |
| Jan 31, 2023 | 364.66% |
| Oct 31, 2022 | -74.20% |
| Jul 31, 2022 | 149.88% |
| Apr 30, 2022 | 62.05% |
| Jan 31, 2022 | -155.99% |
| Oct 31, 2021 | 191.24% |
| Jul 31, 2021 | -63.47% |
| Apr 30, 2021 | 25.05% |